N1 Life

N1 Life, Inc. is a biopharmaceutical company founded in 2019 at Stanford University. The company focuses on the early development (preclinical to early clinical) of new therapies utilizing its barrier-penetrating delivery platform. N1’s delivery technology enables a fast-track strategy to the clinic and consumer markets by maximizing the benefits of known drugs/candidates and existing data, and accessing previously undruggable spaces. N1 Life is creating an innovative and sustainable model encompassing therapeutic pipelines, screening services, and consumer product programs.